Browse by Medical Category
Accepting New Patients
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Results from a Phase 1b/2 clinical trial suggest that an investigational oral therapeutic drug containing the spores of approximately 50 species of beneficial bacteria is effective for the treatment of recurrent C. difficile infection.
A noninvasive method of delivering a promising therapy for persistent C. difficile infection appears to be as effective as treatment via colonoscopy or through a nasogastric tube.
A pilot study by Massachusetts General Hospital MGH investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by C. difficile bacteria.
Back to Top